Last reviewed · How we verify
ADC-189 and Itraconazole — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ADC-189 and Itraconazole (ADC-189 and Itraconazole) — Jiaxing AnDiCon Biotech Co.,Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ADC-189 and Itraconazole TARGET | ADC-189 and Itraconazole | Jiaxing AnDiCon Biotech Co.,Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ADC-189 and Itraconazole CI watch — RSS
- ADC-189 and Itraconazole CI watch — Atom
- ADC-189 and Itraconazole CI watch — JSON
- ADC-189 and Itraconazole alone — RSS
Cite this brief
Drug Landscape (2026). ADC-189 and Itraconazole — Competitive Intelligence Brief. https://druglandscape.com/ci/adc-189-and-itraconazole. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab